Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | %Female (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
147 | Turkish Journal of Cancer | journal | 0.100 Q4 | 10 | 29 | 76 | 545 | 0 | 75 | 0.00 | 18.79 | 43.28 | |
146 | Cancer Research, Therapy and Control | journal | 0.102 Q4 | 13 | 0 | 10 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | |
145 | Leukaemia Risks in Relation to Benzene Exposure | conference and proceedings | 0.102 | 1 | 0 | 9 | 0 | 0 | 9 | 0.00 | 0.00 | 0.00 | |
144 | Biotherapy | journal | 0.106 Q4 | 8 | 58 | 223 | 1226 | 8 | 215 | 0.04 | 21.14 | 5.74 | |
143 | Clinical and Translational Oncology | journal | 0.109 Q4 | 61 | 99 | 291 | 2313 | 22 | 248 | 0.07 | 23.36 | 38.28 | |
142 | Electronic Journal of Oncology | journal | 0.109 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
141 | National Toxicology Program technical report series | journal | 0.109 | 22 | 3 | 16 | 0 | 4 | 16 | 0.27 | 0.00 | 0.00 | |
140 | Women's Oncology Review | journal | 0.109 | 4 | 70 | 139 | 664 | 4 | 126 | 0.02 | 9.49 | 52.27 | |
139 | Acta Oncologica, Supplement | journal | 0.110 Q4 | 8 | 0 | 6 | 0 | 1 | 4 | 0.17 | 0.00 | 0.00 | |
138 | Nowotwory | journal | 0.110 Q4 | 11 | 55 | 140 | 1624 | 13 | 138 | 0.09 | 29.53 | 36.97 | |
137 | Onkologia Polska | journal | 0.110 Q4 | 7 | 43 | 86 | 705 | 6 | 86 | 0.05 | 16.40 | 46.99 | |
136 | Cancer Forum | journal | 0.112 Q4 | 15 | 29 | 96 | 574 | 7 | 93 | 0.05 | 19.79 | 37.14 | |
135 | Tumor Research | journal | 0.115 Q4 | 3 | 4 | 11 | 170 | 1 | 11 | 0.00 | 42.50 | 4.88 | |
134 | Journal of B.U.ON. | journal | 0.116 Q4 | 37 | 93 | 227 | 2430 | 16 | 206 | 0.08 | 26.13 | 34.32 | |
133 | Annals of Cancer Research and Therapy | journal | 0.124 Q4 | 7 | 8 | 40 | 320 | 8 | 38 | 0.13 | 40.00 | 9.68 | |
132 | Japanese Journal of Cancer and Chemotherapy | journal | 0.128 Q4 | 25 | 440 | 1349 | 1633 | 187 | 1349 | 0.13 | 3.71 | 10.44 | |
131 | UroOncology | journal | 0.133 Q4 | 5 | 0 | 105 | 0 | 10 | 95 | 0.13 | 0.00 | 0.00 | |
130 | Reports of Practical Oncology and Radiotherapy | journal | 0.137 Q4 | 36 | 39 | 74 | 709 | 10 | 65 | 0.11 | 18.18 | 38.60 | |
129 | Cancer Genomics and Proteomics | journal | 0.180 Q4 | 50 | 29 | 45 | 1317 | 22 | 45 | 0.49 | 45.41 | 32.56 | |
128 | European Journal of Cancer, Supplement | journal | 0.180 Q4 | 29 | 69 | 116 | 2559 | 40 | 114 | 0.34 | 37.09 | 31.31 | |
127 | Gann Monographs on Cancer Research | book series | 0.196 Q4 | 10 | 0 | 70 | 0 | 22 | 65 | 0.31 | 0.00 | 0.00 | |
126 | Bulletin du Cancer | journal | 0.209 Q4 | 44 | 149 | 576 | 5402 | 359 | 461 | 0.66 | 36.26 | 38.05 | |
125 | Breast Disease | journal | 0.229 Q4 | 36 | 33 | 84 | 2049 | 31 | 77 | 0.44 | 62.09 | 58.06 | |
124 | Neoplasma | journal | 0.325 Q4 | 57 | 84 | 235 | 2729 | 239 | 235 | 0.94 | 32.49 | 39.12 | |
123 | Current Problems in Cancer | journal | 0.327 Q4 | 47 | 20 | 56 | 1124 | 42 | 51 | 0.62 | 56.20 | 46.15 | |
122 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.339 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
121 | Tumori | journal | 0.353 Q4 | 59 | 135 | 602 | 2923 | 555 | 597 | 0.84 | 21.65 | 35.04 | |
120 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.363 Q4 | 56 | 25 | 165 | 1080 | 154 | 153 | 0.99 | 43.20 | 40.37 | |
119 | Medical Oncology | journal | 0.369 Q4 | 90 | 49 | 147 | 1517 | 179 | 142 | 1.04 | 30.96 | 34.89 | |
118 | Journal of Experimental and Clinical Cancer Research | journal | 0.392 Q4 | 120 | 83 | 349 | 2597 | 361 | 344 | 0.89 | 31.29 | 25.06 | |
117 | Brain Tumor Pathology | journal | 0.398 Q4 | 45 | 16 | 61 | 274 | 57 | 61 | 0.78 | 17.13 | 12.94 | |
116 | In Vivo | journal | 0.410 | 72 | 157 | 300 | 5767 | 372 | 299 | 1.22 | 36.73 | 31.83 | |
115 | Oncology Research and Treatment | journal | 0.422 Q4 | 55 | 104 | 346 | 2155 | 380 | 296 | 1.03 | 20.72 | 23.43 | |
114 | Human Cell | journal | 0.436 Q3 | 44 | 18 | 71 | 196 | 74 | 71 | 0.94 | 10.89 | 14.67 | |
113 | Cellular Oncology | journal | 0.462 Q3 | 44 | 34 | 29 | 1347 | 68 | 25 | 2.34 | 39.62 | 31.09 | |
112 | Cytotherapy | journal | 0.476 Q3 | 105 | 62 | 211 | 2455 | 311 | 200 | 1.70 | 39.60 | 31.78 | |
111 | Japanese Journal of Clinical Oncology | journal | 0.504 Q3 | 95 | 135 | 373 | 2926 | 577 | 360 | 1.67 | 21.67 | 16.73 | |
110 | International Journal of Biological Markers | journal | 0.527 Q3 | 47 | 39 | 148 | 1141 | 188 | 136 | 1.11 | 29.26 | 43.23 | |
109 | Oncology | journal | 0.532 Q3 | 83 | 190 | 577 | 4744 | 795 | 553 | 1.03 | 24.97 | 35.06 | |
108 | Technology in Cancer Research and Treatment | journal | 0.534 Q3 | 72 | 79 | 200 | 3878 | 421 | 192 | 2.19 | 49.09 | 26.49 | |
107 | Pathology and Oncology Research | journal | 0.538 Q3 | 61 | 42 | 131 | 1156 | 194 | 127 | 1.55 | 27.52 | 36.55 | |
106 | International Journal of Hyperthermia | journal | 0.549 Q3 | 98 | 65 | 156 | 2855 | 350 | 152 | 2.01 | 43.92 | 16.51 | |
105 | Leukemia and Lymphoma | journal | 0.559 Q3 | 102 | 272 | 1153 | 8936 | 1739 | 1088 | 1.50 | 32.85 | 33.28 | |
104 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.562 Q3 | 35 | 0 | 53 | 0 | 87 | 53 | 4.43 | 0.00 | 0.00 | |
103 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.565 Q3 | 65 | 63 | 152 | 2061 | 272 | 133 | 1.78 | 32.71 | 35.38 | |
102 | Breast | journal | 0.569 | 98 | 113 | 321 | 2794 | 515 | 293 | 1.99 | 24.73 | 37.50 | |
101 | Cancer Cell International | journal | 0.591 Q3 | 80 | 34 | 40 | 1426 | 57 | 39 | 1.88 | 41.94 | 44.55 | |
100 | Clinical Lung Cancer | journal | 0.605 Q3 | 74 | 76 | 206 | 2565 | 284 | 171 | 1.73 | 33.75 | 27.72 | |
99 | Journal of Experimental Therapeutics and Oncology | journal | 0.643 Q3 | 40 | 17 | 104 | 685 | 209 | 103 | 1.83 | 40.29 | 32.10 | |
98 | Oncology Reports | journal | 0.652 Q3 | 115 | 440 | 987 | 11396 | 1748 | 987 | 1.74 | 25.90 | 23.60 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®